Feature | Magnetic Resonance Imaging (MRI) | September 07, 2016

MRIs During Pregnancy Are Safe, But Gadolinium Scans May Increase Risk to Fetus

Study finds MRIs in first trimester of pregnancy were not associated with increased risk

Fetal MRI, safety of MRI in Pregnant women, Philips, Ingenia 1.5T, Cincinnati Children’s Hospital

This study found MRI is safe by itself, but the use of gadolinium contrast may be a factor involved with an array of issues that impact the fetus and young children after birth.  

Fetal MRI, safety of MRI in Pregnant women, Philips, Ingenia 1.5T

September 7, 2016 — In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood. However, data suggests gadolinium contrast enhanced MRI scans at any time during pregnancy may be associated with an increased risk of a broad set of rheumatological, inflammatory or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the Sept. 6, 2016, issue of Journal of the American Medical Association (JAMA).

Concern has been expressed about the safety of MRI exposure in the first trimester of pregnancy due to the heating of sensitive tissues by radiofrequency fields and exposure to the loud acoustic environment. When indicated, MRI's diagnostic accuracy is improved with gadolinium, an intravenous contrast agent. Fetal safety of MRI during the first trimester of pregnancy or with gadolinium enhancement at any time of pregnancy is unknown. While MRI is generally thought to be safe for the fetus in the second or third trimesters of pregnancy, there were no prior controlled studies on its safety in the first trimester, when the fetus forms its major organs and body structures.

 

Watch the VIDEO "MRI Gadolinium Contrast Retention in the Brain."

 

To inform clinical guidelines for MRIs on pregnant women, Joel G. Ray, M.D., M.Sc., FRCPC, of St. Michael's Hospital and the Institute for Clinical Evaluative Sciences, Toronto, and colleagues used health data housed at the Institute for Clinical Evaluative Sciences to examine records of more than 1.4 million births in Ontario from 2003-2015. They compared women who had first-trimester MRIs with those who had not, and also followed their children up to age 4. 

In pregnancies that lasted a minimum of 21 gestational weeks, 1 in 250 had an MRI in pregnancy, including 1 in 1,200 in the first trimester and 1 in 3,000 with gadolinium contrast. Maternal MRI in the first trimester was not associated with a higher risk of stillbirth or neonatal death, congenital anomalies, neoplasm or hearing loss.

"Having an MRI at the earliest stages of pregnancy does not seem to alter the development of the fetus," Ray said.

However, exposure to gadolinium-enhanced MRI at any gestation was not associated with a greater risk of congenital anomalies. Although a nephrogenic systemic fibrosis-like outcome was extremely rare, gadolinium-enhanced MRI was associated with an increased risk for a non-specific outcome of any rheumatological, inflammatory or infiltrative skin condition up to age 4 years, and for stillbirth or neonatal death, although there were just seven events in the gadolinium MRI group.

"The current findings inform published recommendations about the safety of MRI in the first trimester of pregnancy," the authors wrote. "Until further studies are done, these findings suggest that gadolinium contrast should be avoided during pregnancy."

Read the article “Gadolinium May Remain in Brain after Contrast MRI.” 

Even though the actual number of stillbirths was low (one in 50), and the outcome of a skin or rheumatological condition was very broadly defined, Ray said the results support clinical guidelines to avoid giving pregnant women gadolinium unless strongly indicated.

The current study did not include specific information as to why the women received an MRI, or whether they knew they were pregnant at the time. But the study did track the specialty of the physician ordering the MRI: 44 percent were family physicians, suggesting the MRI may have been booked prior to a woman having conceived. The other common specialty was a neurologist or neurosurgeon, suggesting that some women were investigated for headaches or spinal disc issues.

For more information http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.12126

 

Related Gadolinium Safety Concern Articles

Gadolinium May Remain in Brain after Contrast MRI

ACR Manual on Contrast Media Addresses FDA Gadolinium Safety Concerns

Study Finds No Association Between Gadolinium Contrast and Nervous System Disorder

Even High Doses of Gadolinium-Based Contrast Agents Doesn't Cause NSF

Reference: 

1. Joel G. Ray, Marian J. Vermeulen, Aditya Bharatha, et al. “Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes.” JAMA. 2016;316(9):952-961. doi:10.1001/jama.2016.12126.

Related Content

MRI and Computer Modeling Reveals How Wrist Bones Move

Using fast MRI, UC Davis researchers scanned left and right wrists of men and women and used the data to build computer models of the movement of wrist bones. The data could help understand wrist injuries such as carpal tunnel syndrome. Image courtesy of Brent Foster and Abhijit Chaudhari, UC Davis.

News | Magnetic Resonance Imaging (MRI) | February 19, 2019
In a just-published Journal of Biomechanics article, the researchers proved a longtime assumption about individuals'...
Congress Directs FDA to Establish Federal Breast Density Inform Standard
News | Breast Density | February 19, 2019 | Jeff Zagoudis, Associate Editor
As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to...
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

Technology | Advanced Visualization | February 08, 2019
Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi